Microarray Kits Market to be Worth $2.51 Billion by 2031-Exclusive Report by Meticulous Research®

According to a new market research report, 'Microarray Kits Market by Product Type (DNA [cDNA, Oligo, BAC, SNP], RNA, Protein, Tissue), Application (Drug Discovery & Development, Research, Diagnostic), End User (CRO, Pharma & Biotech, Academic, Hospital & Diagnostic Lab) - Global Forecast to 2031', published by Meticulous Research®, the microarray kits market is projected to reach $2.51 billion by 2031, at a CAGR of 5.8% from 2024 to 2031.

Download Sample Report Here @ https://www.meticulousresearch.com/product/microarray-kits-market-5777

Microarray kits are probe-based kits that contain DNA, peptides, proteins, and other small biomolecules that are used to detect certain other molecules. These tests or kits are also used for gene expression and detection of certain genes or molecules that cause a mutation or a disease in a particular patient. These can also be used to create certain personalized medicines for patients as per the condition or the disease.

The growth of the microarray kits market is driven by several factors, including, increasing research applications of microarrays, use of microarrays in cancer research, increasing adoption of personalized medicine, and growing R&D expenditure in pharmaceutical and biotechnology industries. Factors such as technological advancements in microarray technology and emerging economies are a few of the opportunities that would help grow the market in the future. Lack of sensitivity and accuracy could be considered a challenge for the microarray kits market. However, the higher costs of microarrays, as compared to other genetic testing methods, restrain the growth of the market.

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key growth strategies adopted by leading market players in the last three to four years. In recent years, the microarray kits market has witnessed several organic and inorganic strategic developments. The key players profiled in the microarray kits market report are Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.).

Request Sample Report Here @ https://www.meticulousresearch.com/request-sample-report/cp_id=5777

Use Microarrays in Cancer Research

Microarray is a chip-based technology that is used to detect and quantify various kinds of biomolecules, such as DNA, RNA, and proteins, among others. This is considered an ideal way to study the different genes or biomarkers found in a specific type of cancer. There has been an increase in the number of cancer cases detected across the world in several countries. As per the World Health Organization (WHO) estimates, the global prevalence of cancer is expected to increase from 19.2 million new cases in 2020 to 24.5 million new cases in 2030, while the total mortalities from cancer are expected to increase from 9.9 million deaths in 2020 to 12.9 million deaths in 2030.

There is wide availability of microarrays, which are fast and reliable solutions for a variety of high throughput needs in biomarker discovery in cancer research. For instance, the lectin microarray is a technology that utilizes lectins immobilized on a well-defined substrate for high-throughput analysis of glycans and glycoproteins. This technique is now being used in cancer biomarker identification by tagging the lectins with fluorescent-tagged samples and then monitoring this through a fluorescence detection system. This helps in obtaining better and more rapid results.

The microarray kits market is segmented by Product Type (DNA Microarray Kits [cDNA Microarray Kits, Oligo Microarray Kits, BAC Microarray Kits, and SNP Microarray Kits], RNA Microarray Kits, Protein Microarray Kits, and Tissue Microarray Kits), Application (Drug Discovery & Development, Research Applications, Diagnostics, and Other Applications), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research & Academic Institutes, Hospitals & Diagnostic Laboratories, and Other End Users), and Geography.

Customize Report @ https://www.meticulousresearch.com/request-customization/cp_id=5777

Among all product types, in 2024, the DNA microarray kits segment is expected to account for the largest share of the market. DNA microarray kits are kits that are used to detect and quantify the amount of DNA present in a given sample. The large market share of the segment is attributed to factors such as increasing prevalence of chronic and genetic diseases, increasing funding for genomic R&D, increased accuracy in results, higher number of sample testing at a time, and growing research for personalized medicine.
According to the World Health Organization (WHO), as of February 2023, approximately 240,000 newborns die across the world within 28 days of birth due to congenital disorders. Microarray technology or microarray kits are used to detect large changes in the structures of chromosomes or microscopic abnormalities as well. Thus, the use of this technology in the diagnosis of diseases drives the demand for microarray kits. For instance, the Nationwide Children's Hospital (U.S.) provides a genetic test called the Helping Hand, which is a microarray analysis test that tests for any chromosome deletion, duplication, or large parts of multiple chromosomes being the same.

Among applications, in 2024, the drug discovery & development segment is expected to account for the largest share of the market. Drug discovery & development include the experiments that are conducted to test certain drugs or theories that can be applied to a particular disease treatment. The large market share of the segment is attributed to factors such as growing R&D expenditure, a large number of academic and research institutes focusing on cancer research, and growing innovations in the field of microarray technology.

Among end users, in 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market. Pharmaceutical and biotechnology companies use microarray kits and technology for various applications such as drug discovery, cancer biomarker detection, and personalized medicines. The large share of the market is attributed to factors such as a growing focus on drug discovery & development, and rising pharmaceutical R&D expenditure, and increased adoption of personalized medicines. In the case of personalized medicine, DNA microarray kits can be used to compare diseased tissues/cells with healthy tissues/cells in order to find the characteristics of a disease. In the case of drug discovery & development, protein microarray kits are used to screen patients and then prescribe drugs to exclude potential side effects and determine the most suitable dose, hence driving the growth of the segment.

Quick Buy: https://www.meticulousresearch.com/Checkout/54315627

Office No-202, 203,204,205,206 2nd Floor, Pushpak Business Hub, Wakad, , India.

About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

This release was published on openPR.